HuGE Literature Finder
Records 1-30
|
Pathological characteristics, survival, and risk of breast cancer associated with estrogen and xenobiotic metabolism polymorphisms in Mexican women with breast cancer.
Cancer causes & control : CCC 2021 Jan . Martínez-Ramírez O C, Castro-Hernández C, Pérez-Morales R, Casas-Ávila L, de Lorena Ramos-García M, Salazar-Piña A, Rubio |
|
The association between genetic variants in the genes for cytochrome P450 B1 and ATP-binding cassette transporter genes and breast cancer risk.
Molecular biology reports 2020 Jul . ShahidSales Soodabeh, Mehramiz Mehrane, Radmanesh Davood, Rastgar-Moghadam Azam, Hassanian Seyed Mahdi, Khazaei Majid, Ghazizade Hamideh, Ferns Gordon A, Avan Am |
|
Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population.
BMC medical genetics 2019 Sep 20 (1): 148. Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame |
|
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk.
Endocrine connections 2019 Jul . Rizzolo Piera, Silvestri Valentina, Valentini Virginia, Zelli Veronica, Bucalo Agostino, Zanna Ines, Bianchi Simonetta, Tibiletti Maria Grazia, Russo Antonio, Varesco Liliana, Tedaldi Gianluca, Bonanni Bernardo, Azzollini Jacopo, Manoukian Siranoush, Coppa Anna, Giannini Giuseppe, Cortesi Laura, Viel Alessandra, Montagna Marco, Peterlongo Paolo, Radice Paolo, Palli Domenico, Ottini Lau |
|
Association between polymorphisms in estrogen metabolism genes and breast cancer development in Chinese women: A prospective case-control study.
Medicine 2018 Nov 97 (47): e13337. Qiu Juanjuan, Du Zhenggui, Liu Jingping, Zhou Yi, Liang Faqing, Lü Qi |
|
Interaction between dietary acrylamide intake and genetic variants for estrogen receptor-positive breast cancer risk.
European journal of nutrition 2018 Feb . Hogervorst Janneke G F, van den Brandt Piet A, Godschalk Roger W L, van Schooten Frederik-Jan, Schouten Leo |
|
Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial.
Pharmacogenetics and genomics 2018 11 28 (11): 245-250. Ruiz-Pinto Sara, Martin Miguel, Pita Guillermo, Caronia Daniela, de la Torre-Montero Julio C, Moreno Leticia T, Moreno Fernando, García-Sáenz José Á, Benítez Javier, González-Neira An |
|
[Exploratory study of circulating tumor DNA detection in early breast cancer: an analysis of 75 next-generation sequencing results].
Zhonghua wai ke za zhi [Chinese journal of surgery] 2017 Nov 55 (11): 847-852. Zhou B, Xin L, Xu L, Liu Y H, Zhang M M, Jing R L, Liang X Y, Cao S |
|
Polymorphism in xenobiotic and estrogen metabolizing genes, exposure to perfluorinated compounds and subsequent breast cancer risk: A nested case-control study in the Danish National Birth Cohort.
Environmental research 2017 Jan 154 325-333. Ghisari Mandana, Long Manhai, Røge Durita Mohr, Olsen Jørn, Bonefeld-Jørgensen Eva |
|
Cytochrome P-450 1B1 Leu432Val Polymorphism Does Not Show Association With Breast Cancer in Northern Iranian Women With a History of Infertility.
Biomarker insights 2017 12 1177271916689058. Andarieh Maryam Ghanbari, Zabihi Ebrahim, Moslemi Dariush, Delavar Mouloud Agajani, Haji-Ahmadi Mahmoud, Monfared Ali Shabestani, Jorsaraei Seyed Gholam Ali, Ghasemi Masoumeh, Esmaeilzadeh Sedig |
|
Genetic polymorphisms of phase I metabolizing enzyme genes, their interaction with lifetime grilled and smoked meat intake, and breast cancer incidence.
Annals of epidemiology 2016 Nov . Parada Humberto, Steck Susan E, Cleveland Rebecca J, Teitelbaum Susan L, Neugut Alfred I, Santella Regina M, Gammon Marilie |
|
Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.
Oncotarget 2016 Oct 7 (41): 66790-66808. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Grzybowska E |
|
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.
The pharmacogenomics journal 2016 Aug . Hertz D L, Kidwell K M, Seewald N J, Gersch C L, Desta Z, Flockhart D A, Storniolo A-M, Stearns V, Skaar T C, Hayes D F, Henry N L, Rae J |
|
ssociation of Cytochrome P450-1B1 Gene Polymorphisms with Risk of Breast Cancer: an Egyptian Study.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (6): 2861-6. Ibrahim Mona H, Rashed Reham A, Hassan Naglaa M, Al-Azhary Nevin M, Salama Asmaa I, Mostafa Marwa |
|
Hormone-related pathways and risk of breast cancer subtypes in African American women.
Breast cancer research and treatment 2015 Oct . Haddad Stephen A, Lunetta Kathryn L, Ruiz-Narváez Edward A, Bensen Jeannette T, Hong Chi-Chen, Sucheston-Campbell Lara E, Yao Song, Bandera Elisa V, Rosenberg Lynn, Haiman Christopher A, Troester Melissa A, Ambrosone Christine B, Palmer Julie |
|
Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.
Molecular genetics and genomics : MGG 2015 Apr 290 (2): 739-65. Liu Jie-Ying, Yang Yu, Liu Zhi-Zhong, Xie Jian-Jun, Du Ya-Ping, Wang W |
|
Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women.
Journal of cancer research and clinical oncology 2015 Apr 141 (4): 633-45. Son Byung Ho, Kim Mi Kyung, Yun Young Mi, Kim Hee Jeong, Yu Jong Han, Ko Beom Seok, Kim Hanna, Ahn Sei Hy |
|
Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial.
The pharmacogenomics journal 2015 Feb 15 (1): 63-8. Le Morvan V, Litière S, Laroche-Clary A, Ait-Ouferoukh S, Bellott R, Messina C, Cameron D, Bonnefoi H, Robert |
|
Cytochrome P1B1 (CYP1B1) polymorphisms and cancer risk: a meta-analysis of 52 studies.
Toxicology 2015 Jan 327 77-86. Li Cuiping, Long Bingshuang, Qin Xianjing, Li Weixiong, Zhou Ya |
|
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.
Breast cancer research : BCR 2015 17 (1): 110. Rudolph Anja, Fasching Peter A, Behrens Sabine, Eilber Ursula, Bolla Manjeet K, Wang Qin, Thompson Deborah, Czene Kamila, Brand Judith S, Li Jingmei, Scott Christopher, Pankratz V Shane, Brandt Kathleen, Hallberg Emily, Olson Janet E, Lee Adam, Beckmann Matthias W, Ekici Arif B, Haeberle Lothar, Maskarinec Gertraud, Le Marchand Loic, Schumacher Fredrick, Milne Roger L, Knight Julia A, Apicella Carmel, Southey Melissa C, Kapuscinski Miroslav K, Hopper John L, Andrulis Irene L, Giles Graham G, Haiman Christopher A, Khaw Kay-Tee, Luben Robert, Hall Per, Pharoah Paul D P, Couch Fergus J, Easton Douglas F, Dos-Santos-Silva Isabel, Vachon Celine, Chang-Claude Jen |
|
ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors.
SpringerPlus 2015 4 327. Dumont Aurélie, Pannier Diane, Ducoulombier Agnès, Tresch Emmanuelle, Chen Jinying, Kramar Andrew, Révillion Françoise, Peyrat Jean-Philippe, Bonneterre Jacqu |
|
Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers.
Current drug metabolism 2015 16 (10): 850-63. He Xin, Feng Sh |
|
Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach.
Gene 2014 Jun 543 (1): 69-75. Tulsyan Sonam, Chaturvedi Pankaj, Singh Abhishek Kumar, Agarwal Gaurav, Lal Punita, Agrawal Sushma, Mittal Rama Devi, Mittal Balr |
|
Adipose tissue PCB levels and CYP1B1 and COMT genotypes in relation to breast cancer risk in postmenopausal Danish women.
International journal of environmental health research 2014 24 (3): 256-68. Bräuner Elvira V, Loft Steffen, Wellejus Anja, Autrup Herman, Tjønneland Anne, Raaschou-Nielsen O |
|
Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women.
Environmental health : a global access science source 2014 13 (1): 19. Ghisari Mandana, Eiberg Hans, Long Manhai, Bonefeld-Jørgensen Eva |
|
Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women.
Breast (Edinburgh, Scotland) 2013 Jun 22 (3): 335-43. Martínez-Ramírez O C, Pérez-Morales R, Castro C, Flores-Díaz A, Soto-Cruz K E, Astorga-Ramos A, Gonsebatt M E, Casas L, Valdés-Flores M, Rubio |
|
Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.
Cancer epidemiology 2012 Oct 36 (5): 445-52. Lundin Eva, Wirgin Isaac, Lukanova Annekatrin, Afanasyeva Yelena, Krogh Vittorio, Axelsson Tomas, Hemminki Kari, Clendenen Tess V, Arslan Alan A, Ohlson Nina, Sieri Sabina, Roy Nirmal, Koenig Karen L, Idahl Annika, Berrino Franco, Toniolo Paolo, Hallmans Göran, Försti Asta, Muti Paola, Lenner Per, Shore Roy E, Zeleniuch-Jacquotte An |
|
Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users.
Breast cancer research : BCR 2012 14 (5): R135. Ellingjord-Dale Merete, Lee Eunjung, Couto Elisabeth, Ozhand Ali, Qureshi Samera, Hofvind Solveig, Van Den Berg David J, Akslen Lars A, Grotmol Tom, Ursin Gis |
|
Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada.
The breast journal 0 20 (5): 468-80. Cotterchio Michelle, Mirea Lucia, Ozcelik Hilmi, Kreiger Nan |
|
CYP1A1, CYP1B1, GSTM1 and GSTT1 genetic variants and breast cancer risk in Mexican women.
Salud publica de Mexico 0 59 (5): 540-547. García-Martínez Angélica, Gamboa-Loira Brenda, Tejero M Elizabeth, Sierra-Santoyo Adolfo, Cebrián Mariano E, López-Carrillo Lizbe |
- Page last reviewed:Oct 1, 2020
- Page last updated:Mar 05, 2021
- Content source: